Treatment experiences with new agents, including therapy-related decisions and managing side effects

During the latest Know AML Ambassador Meeting, Lizzie Dean, a Know AML Ambassador, delivered a patient-led discussion on treatment experiences with new agents, including therapy-related decisions and managing side effects.

Lizzie discusses her experiences and challenges with new acute myeloid leukemia treatment options, including treatment-related decisions, such as evaluating the treatment options, the impact on quality of life, travel costs, and trial withdrawal​.